Clinical Impact of Tirzepatide on COPD Patients: Observational Study Results

Jheng-Yan Wu's research dataset contains results from an observational study on the clinical impact of tirzepatide on patients with chronic obstructive pulmonary disease. The study analyzed data from 12,110 patients after propensity score matching, sourced from the TriNetX Global Collaborative Network between January 2022 and February 2025. The dataset was last updated on 2026-05-20.

Use Cases

• Assessing the association between tirzepatide use and COPD exacerbation risk based on the reported hazard ratios.
• Analyzing secondary outcomes like mortality, pneumonia, and acute respiratory failure in COPD patients based on the study's results.
• Benchmarking observational study designs in pharmacoepidemiology based on the described methodology using a large collaborative network.

Strengths

• Dataset is based on a study with 12,110 patients after matching, providing a substantial sample size.
• Results include specific hazard ratios and confidence intervals for primary and secondary outcomes.
• Data is shared under a permissive CC-BY-4.0 license.

Limitations

• The dataset is a 48.2 KB document file; the underlying patient-level data is not directly accessible.
• The description notes inherent limitations of observational designs, including potential residual confounding and selection bias.
• Column-level documentation and row count for the source data are unknown.

Provenance

Source

TriNetX Global Collaborative Network

Collection Method

Observational study using electronic health records, with propensity score matching applied.

Time Range

January 2022 to February 2025

Freshness

Last updated 2026-05-20 12:00:17